Credit Suisse Upgrades Eli Lilly (LLY) to Outperform

October 9, 2015 6:36 AM

Credit Suisse upgraded Eli Lilly (NYSE: LLY) from Neutral to Outperform with a price target of $105.00 (from $89.00).Analyst V ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found